CKD Bio (063160.KS) Earnings Analysis
CKD Bio (063160.KS) has no confirmed upcoming earnings date. Trailing P/E -12.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 063160.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 063160.KS. This page updates as the calendar is published.
063160.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-24 | -369.85 KRW | n/a | n/a | n/a |
| 2026-01-30 | -205.7 KRW | n/a | n/a | n/a |
| 2025-05-15 | 164.06 KRW | n/a | n/a | n/a |
| 2025-03-18 | 215.04 KRW | n/a | n/a | n/a |
| 2024-10-25 | 51.95 KRW | n/a | n/a | n/a |
| 2024-07-26 | 802.79 KRW | n/a | n/a | n/a |
063160.KS valuation and analyst view
| Trailing P/E | -12.57 |
|---|---|
| Trailing EPS | -1,060.4293 KRW |
| Price / book | 0.58 |
| Dividend yield | 0.00% |
| Market cap | 70.33B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is CKD Bio (063160.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 063160.KS. This page updates as the calendar is published.
Did 063160.KS beat earnings last quarter?
Consensus estimate data was not available for 063160.KS's 2026-04-24 report.
What is 063160.KS's current P/E ratio and EPS?
063160.KS trades at a trailing P/E of -12.57 on trailing EPS of -1060.4292982136346 KRW.
What do analysts rate 063160.KS?
063160.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.